GFAP and Alzheimer disease: The anti-NMDAR encephalitis patients had longer hospital and higher incidence of clinical manifestations including psycho-behavioral abnormalities, involuntary movements, speech disorder, and sleep disorder than the MOG-AD patients and autoimmune GFAP-A patients.